Objective: To investigate the use of ambulatory blood pressure monitoring (ABPM) in identifying and managing a group of patients referred to a tertiary centre for the assessment of their blood pressure and to illustrate the importance of introducing standardised ABPM treatment guidelines.
Introduction
Ambulatory blood pressure monitoring (ABPM) has proved to be useful in assessing levels of blood pressure away from hospital or a medical environment. It is of great importance in distinguishing between true hypertension and 'white coat' hypertension (WCH) and has proved to be uniquely successful in this area. 1 It has long been established that ABPM is not only more reproducible than office measurements, but also more closely related to the incidence of cardiovascular events and the prevalence of end organ damage. 2 There is substantial evidence that ABP correlates better with left ventricular mass index (LVMI) than casual readings. This is of ABPM reduces variability introduced by the observer such as digit preference, threshold avoidance and bias, and increases reproducibility. One of the rationales for using 24-h monitoring is that it is thought to be more representative of a patient's true blood pressure and is more reproducible than clinic readings. 4 ABPM has advanced as a research instrument from assessing the efficacy of new treatments to a valuable accessory in the hypertension clinic and general practice.
With the increasing use of ABPM in the clinical management of hypertensive patients, treatment levels are being reassessed and guidelines prepared. Although ABPM has been in widespread use there has not been a consensus on the levels that should be used as guidelines for treatment. Many studies We decided to see how our group of patients would fit into the current definitions and the impact that this could have on their treatment and possible management.
Patients and methods
The patients in this study were a consecutive series of patients referred to our hypertension clinic for investigation of suspected or confirmed hypertension. They represent all patients referred to the Hypertension Clinic of the Royal Brompton & Harefield NHS Trust over a 5-year period. All patients had been referred primarily from primary care with smaller numbers from consultants or from other hospitals. There were no specific referral criteria required as this was at the discretion of the clinician. The main reasons for referrals were: suspected white coat hypertension, borderline hypertension, resistant hypertension, episodic hypertension and investigating causes of secondary hypertension.
All patients wore an ABPM for 24 h. Hypertension nurse specialists, who have been extensively trained in ABPM, fitted each recorder. All patients were given written and oral information of the procedure and techniques to establish a good recording. Three clinic readings were taken after a seated period of at least 5 min and the same recorder was used as would be used for the 24-h recording. The monitor was programmed to measure the blood pressure every 15 min during the day and every 30 min at night. Sleep periods were programmed as suggested by the patient who were also asked to keep a simple diary confirming at what times they were awake and asleep. We required at least 20 awake readings to consider the recording satisfactory for analysis purposes.
We used the TM 2420 (A&D, Tokyo, Japan), a microphonic monitor using Korotkoff sounds I and V to determine systolic and diastolic blood pressure (SBP/DBP). This monitor has been extensively validated and passes the AAMI criteria for ambulatory accuracy. 5 Data was read automatically by proprietary software (A&D) and transferred to a dedicated computer program for analysis. Readings excluded as faulty by the monitors were excluded from the analysis, but no other data were rejected in order to exclude any subjective bias. The data was analysed to calculate averages for waking and sleeping SBP and DBP, and pulse rate (definitions were based on diary entries).
We looked at 2000 sequential recordings and excluded those that were not first time referrals, which left 1557. The grouped data was then analysed and stratified according to different classifications (see definitions). We investigated what proportion of the total population of our patients would have had been classified as established hypertensives/borderline hypertensive or normotensive based on published criteria: for clinic readings using the BHS guidelines, 6 and then for ABP levels using levels suggested by O'Brien 7 (Table 1 ). In this particular patient population we analysed the prevalence of a significant white coat effect (WCE), (Table 2) . We employed the definition used in the substudy of the Second Australian National Blood Pressure Study (ANBP2). 8 A WCE is not exclusive to normotensive patients and can equally be present in those patients with hypertension. In this latter group however it might lead to excessive antihypertensive dose increases. We then divided the data by treatment groups (Table 3) to see how the different guidelines would effect treatment strategies.
Definitions

BHS Guidelines
6 : Established hypertension is defined as clinic SBP у160 mm Hg and/or DBP у100 mm Hg, normotensive clinic SBP р139 mm Hg and/or DBP р89 mm Hg and borderline between these.
Guidelines after O'Brien et al
Daytime ABP levels were defined as blood pressures у140 and/or 90 mm Hg being probably abnormal and blood pressures below р135/85 mm Hg are probably normal
White coat effect from Second Australian National Blood Pressure Study (ANBP2)
8 : Clinic SBP у20 mm Hg higher than ABP or clinic DBP у10 mm Hg.
White coat hypertension:
Daytime ABPM р139/89 mm Hg and clinic readings у160 and/or DBP у100 mm Hg.
Results
We examined 1557 ABPM recordings, which were all first time referrals for ABPM. We saw an even sex distribution of 789 men and 768 women with a mean age 53 ± 13.8 (12-88 years).
White coat hypertension and white coat effect
A total of 542 of all patients (35%) exhibited a WCE (SBP reduced by 20 mm Hg or DBP reduced by 10 mm Hg on ABPM compared with the average of three clinic readings).
A total of 526 patients had a normal/borderline ABPM reading as defined by O'Brien 7 (Table 1) eg, р139/89 mm Hg.
A total of 81 (15%) had a clinic reading average у160 and/or у100 mm Hg and so met our definition of WCH, 46 were receiving antihypertensive treatment and 35 were not receiving any treatment (Table 2) .
If we use broader definitions the prevalence of WCH increases. For those patients whose office blood pressure у140 and/or у90 mm Hg we stratified the patients according to the following subdivisions of daytime ABP levels to assess the proportions of patients that would meet this diagnosis:
• р139/89 mm Hg ϭ 264 (17%) • р135/85 mm Hg ϭ 158 (10%)
Journal of Human Hypertension
• р130/80 mm Hg ϭ 72 (5%) Therefore using the broadest definition we can claim that 17% of our population had WCH.
Of the 1031 patients whose blood pressure was not well controlled according to their ABP (Table 3) , 78 (8%) would not have had treatment initiated or changed according to their clinic readings. A further 312 (30%) of this group were borderline for treatment according to their clinic readings. Of the 722 patients whose blood pressure was uncontrolled according to their clinic readings, 43 (6%) had good blood pressure control according to their ABPM.
Discussion
This centre is unusual as it attracts referrals for patients who have already had cardiovascular problems identified. However, with that in mind and having introduced ABPM to this centre we are interested to see how it may influence the management of patients referred with 'hypertension'.
We are also aware that this is of particular relevance and interest given the current debate and controversy regarding levels of normality as published in the WHO/ISH guidelines 9 and the consequent discussion in the Lancet. 10 It is disappointing that these guidelines have not gone further in clarifying the issue of ABPM. Although recognising the benefits of ABPM they fall short of advocating its use in practice. On one hand they stress the need for more prognostic studies to confirm the advantages of ABPM and then appear to contradict this by confirming that ABPM does have a prognostic value and is superior in correlating high levels of blood pressure with target organ damage. In the light of these disparities it appears even more pressing to have a consensus over 'normal' ABP levels. In our discussion we have used the levels that have been advocated by Professor O'Brien.
The 35 patients with white coat hypertension who were not receiving treatment would almost certainly have had treatment commenced on the basis of their clinic readings measured in the clinic setting. It is also likely that the 46 who were already receiving antihypertensive treatment may have had it increased on the basis of these office measurements. This group of patients with highly divergent ABPM and clinic readings is relatively small (81 is only 5% of the total) (however this figure increases to 17% using broader definitions). Table 2 describes these 35 patients who would have been prescribed treatment on the basis of their clinic reading had they not been referred for ABP. Unfortunately we do not have follow-up details on this group of 35 patients as they come from such diverse referral sources.
In Table 1 , 67% of our group would be classified as hypertensive or having uncontrolled hypertension according to their daytime ABP levels, if the BHS guidelines are applied to their clinic readings this would have fallen to 46%. This means 309 patients possibly being under-treated or not treated at all. The results demonstrate the importance of establishing standard levels to use in managing and treating blood pressure, slight differences in groupings obviously result in large numbers of patients being mismanaged; either not being detected or being over-treated. Despite the difference in the number of patients in the hypertensive group and the borderline group an interesting point is that both definitions concur with each other with exactly the same number of patients (21%) having normal blood pressures.
In Table 3 the same patient group of 1557 has been stratified according to treatment levels, and shows that 43 patients may have been started on antihypertensive therapy according to their clinic readings but would not have been according to their ABP results. The results in this table support those in Table 1 . However, 78 patients with normal clinic readings would have had treatment indicated by their ABPM levels. This illustrates the disparity between the recommended guidelines for definite treatment between clinic and ABP, which is a difference of 20 mm Hg SBP and 10 mm Hg DBP. It appears from this table that if ABPM is performed it results in more patients being possibly treated if O'Brien's guidelines are used. This is unsurprising as many more readings are taken during a 24-h per-
